Several listed companies in Shanghai and Shenzhen issued important announcements on March 9. The following is a summary of good news:
Wingtech Technology Co.Ltd(600745) : successful production of new products in semiconductor business
Wingtech Technology Co.Ltd(600745) ( Wingtech Technology Co.Ltd(600745) ) announced on March 9 that the insulated gate bipolar transistor (IGBT) series products independently designed and developed by the company have been successfully streamed, made phased significant progress, and all parameters meet the design requirements. IGBT is the core device of power conversion and a high-quality track in semiconductors. After successful IGBT production, it still needs to be verified by customers, and the subsequent mass production plan is uncertain.
Cnnc Hua Yuan Titanium Dioxide Co.Ltd(002145) : comprehensively increase the selling price of titanium dioxide of various models
Cnnc Hua Yuan Titanium Dioxide Co.Ltd(002145) ( Cnnc Hua Yuan Titanium Dioxide Co.Ltd(002145) ) announced on March 9 that the sales price of various models of titanium dioxide of the company will be comprehensively increased from March 9. Among them, the sales price of Chinese customers increased by 1000 yuan / ton and that of international customers increased by 150 dollars / ton.
Guangdong Dowstone Technology Co.Ltd(300409) : the subsidiary plans to increase capital and shares, introduce war investment and build a three yuan precursor project with an annual output of 100000 tons
Guangdong Dowstone Technology Co.Ltd(300409) ( Guangdong Dowstone Technology Co.Ltd(300409) ) announced on the evening of September 9 that the company plans to increase capital and shares of its subsidiary Wuhu Jiana by introducing strategic investors and establishing a shareholding platform for senior management team, of which the strategic investors plan to increase capital by 1.44 billion yuan in cash; The shareholding platform of the senior management team increased its capital by 30 million yuan in cash. The total capital increase of 1.47 billion yuan will be used for the investment and construction of a three yuan precursor project with an annual output of 100000 tons in Wuhu City. In addition, Hong Kong Jiana, a wholly-owned subsidiary of the company, plans to increase capital to Indonesia Jiana within two years, with a capital increase of no more than 1.272 billion yuan, so as to ensure the supply of nickel resources and reduce the cost of high nickel ternary precursor products.
Huaneng Lancang River Hydropower Inc(600025) : it is planned to invest 5 billion yuan to develop new energy projects in 2022
Huaneng Lancang River Hydropower Inc(600025) ( Huaneng Lancang River Hydropower Inc(600025) ) disclosed the investment plan of new energy business in 2022 on March 9. In 2021, the company completed the approval (filing) of 3.868 million kw of new energy and started the construction of 990000 kW. In 2022, the company plans to invest 5 billion yuan to develop new energy projects, and plans to start 15 new projects with an installed capacity of 1.3 million KW.
Zhongnongfa Seed Industry Group Co.Ltd(600313) : the person acting in concert of the actual controller plans to increase the holding of 1% – 2% shares
Zhongnongfa Seed Industry Group Co.Ltd(600313) ( Zhongnongfa Seed Industry Group Co.Ltd(600313) ) announced on March 9 that Huanong assets, the concerted action of the actual controllers of the company, increased its holdings of 8.7782 million shares of the company by means of centralized bidding on March 9, and plans to continue to increase its holdings of 1% – 2% shares of the company at the right time (including the increased holdings of shares this time).
Hengli Petrochemical Co.Ltd(600346) : it is proposed to repurchase shares of RMB 1 billion to RMB 1.5 billion
Hengli Petrochemical Co.Ltd(600346) ( Hengli Petrochemical Co.Ltd(600346) ) announced on March 9 that it plans to repurchase shares at a price of 1-1.5 billion yuan, with a repurchase price of no more than 30 yuan / share. The repurchased shares are intended to be used in the employee stock ownership plan.
Flat Glass Group Co.Ltd(601865) : at present, there are sufficient orders for photovoltaic glass, which confirms the strong market demand
Flat Glass Group Co.Ltd(601865) ( Flat Glass Group Co.Ltd(601865) ) on March 9, the announcement on sufficient orders for the industry was released. The photovoltaic industry showed a significant off-season feature in January and February, and the industry production scheduling continued to rise. With the development of the industry, the company also accelerated the production expansion of photovoltaic glass to meet the needs of the market. At present, due to the upward boom of the industry, the company has sufficient orders for photovoltaic glass, which confirms the strong market demand.
Tonghua Dongbao Pharmaceutical Co.Ltd(600867) : 12-24 million shares to be repurchased
Tonghua Dongbao Pharmaceutical Co.Ltd(600867) ( Tonghua Dongbao Pharmaceutical Co.Ltd(600867) ) announced on March 9 that it is planned to repurchase 12-24 million shares at a price of no more than RMB 360 million, with a repurchase price of no more than RMB 15 / share. The repurchased shares will be cancelled and the registered capital of the company will be reduced.
Huaxin Cement Co.Ltd(600801) : it is estimated that the capacity of cement and other industries will expand in 2022, and the company will enter a period of rapid growth
Huaxin Cement Co.Ltd(600801) ( Huaxin Cement Co.Ltd(600801) ) announced on March 9 that in 2022, benefiting from integrated operation and international development, it is expected that the production capacity of cement, aggregate and concrete will expand and the company will enter a period of rapid growth. The company has formulated a doubling development plan, which plans to invest nearly 60 billion yuan during the 14th Five Year Plan period to continuously upgrade the business sectors of cement, aggregate, concrete, new materials and environmental protection, so as to promote the transformation and upgrading of enterprises and high-quality development. In 2021, the company’s capital expenditure was about 7.16 billion yuan, an increase of nearly 68% over 2020. In 2022, the company plans to make capital expenditure of about 12.2 billion yuan to rapidly promote the implementation of the company’s development strategy.
China Meheco Group Co.Ltd(600056) : will be responsible for Pfizer COVID-19 therapeutics PAXLOVID Chinese mainland market business operation
China Meheco Group Co.Ltd(600056) ( China Meheco Group Co.Ltd(600056) ) announced in March 9th that the company signed an agreement with Pfizer Inc that it will be responsible for the commercial operation of Pfizer Inc COVID-19 virus treatment PAXLOVID in Chinese mainland market in the period of agreement (2022). The final use and sales of products are greatly uncertain due to factors such as epidemic prevention and control, and it is expected that the relevant business scale accounts for a small proportion of the company’s overall business volume, which has no significant impact on the company’s recent operating performance.
